PnuVax
  • Home
  • About pnuVax
      • Team
      • MissionĀ 
      • Facilities
      • Collaborations
      • Contact us
  • Pneumonia Vaccine
  • Pipeline of innovation
  • Investors and Media
    • News
  • careers
Select Page
  • Home
  • About pnuVax
      • Team
      • MissionĀ 
      • Facilities
      • Collaborations
      • Contact us
  • Pneumonia Vaccine
  • Pipeline of innovation
  • Investors and Media
    • News
  • careers
PnuVax awarded $29.4 million USD grant to advance innovative vaccine into clinical trials

PnuVax awarded $29.4 million USD grant to advance innovative vaccine into clinical trials

by admin | Oct 26, 2023 | Uncategorized

Pneumonia, one of the diseases caused by pneumococcal bacteria, is currently the leading single killer of young children worldwide, despite advances in prevention and treatment $29.4 million USD grant from the Bill & Melinda Gates Foundation will advance...
PnuVax Announces Deal with GE for Inactivated Yellow Fever Vaccine IP

PnuVax Announces Deal with GE for Inactivated Yellow Fever Vaccine IP

by admin | Oct 26, 2023 | Uncategorized

Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced...
PnuVax Announces Deal with GE for Inactivated Yellow Fever Vaccine IP

PnuVax Announces Preclinical In-vivo Pneumococcal Conjugate Vaccine Immunogenicity Results

by admin | Oct 26, 2023 | Uncategorized

Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced...

Recent Posts

  • PnuVax awarded $29.4 million USD grant to advance innovative vaccine into clinical trials
  • PnuVax Announces Deal with GE for Inactivated Yellow Fever Vaccine IP
  • PnuVax Announces Preclinical In-vivo Pneumococcal Conjugate Vaccine Immunogenicity Results

Recent Comments

No comments to show.
logo

Sign up for the Divi mailing list

Success!

Subscribe

Calendar
Tickets
Ticket Policies
The Venue
Events
About
FAQ
Terms & Conditions
Privacy
Sitemap
Contact
Contact Us
Memberships
Get the App
Exhibits
Watch Online
  • Follow
  • Follow
  • Follow